The Hidden Risk of Toxoplasmosis in the Expanding Immunomodulated Host Population: A Call for Guidelines and Registries in Patients on Biologics, Small Molecules, and Cellular Therapies.

Montoya JG, Cho SM, Smith S, Gomez CA, Contopoulos-Ioannidis DG

Open source

DOI
10.3390/pathogens15070696
Published
2026 Jun 30
Container
Pathogens (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pathogens15070696,
  title = {The Hidden Risk of Toxoplasmosis in the Expanding Immunomodulated Host Population: A Call for Guidelines and Registries in Patients on Biologics, Small Molecules, and Cellular Therapies.},
  author = {Montoya JG and Cho SM and Smith S and Gomez CA and Contopoulos-Ioannidis DG},
  year = {2026},
  journal = {Pathogens (Basel, Switzerland)},
  doi = {10.3390/pathogens15070696},
  url = {https://doi.org/10.3390/pathogens15070696}
}

RIS

TY  - JOUR
TI  - The Hidden Risk of Toxoplasmosis in the Expanding Immunomodulated Host Population: A Call for Guidelines and Registries in Patients on Biologics, Small Molecules, and Cellular Therapies.
AU  - Montoya JG
AU  - Cho SM
AU  - Smith S
AU  - Gomez CA
AU  - Contopoulos-Ioannidis DG
PY  - 2026
JO  - Pathogens (Basel, Switzerland)
DO  - 10.3390/pathogens15070696
UR  - https://doi.org/10.3390/pathogens15070696
ER  - 

APA

JG, M., SM, C., S, S., CA, G., & DG, C. (2026). The Hidden Risk of Toxoplasmosis in the Expanding Immunomodulated Host Population: A Call for Guidelines and Registries in Patients on Biologics, Small Molecules, and Cellular Therapies.. Pathogens (Basel, Switzerland). https://doi.org/10.3390/pathogens15070696

Source records